Label: CETIRIZINE HYDROCHLORIDE tablet

  • NDC Code(s): 10135-762-01, 10135-762-03, 10135-762-05, 10135-762-30, view more
    10135-762-90
  • Packager: Marlex Pharmaceuticals, Inc
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated October 3, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active ingredient (in each tablet)

    Cetirizine HCl, USP 10 mg

  • Purpose

    Antihistamine

  • Uses

    temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

    • runny nose
    • sneezing
    • itchy, watery eyes
    • itching of the nose or throat
  • Warnings

    Do not useif you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.

    Ask a doctor before use if you haveliver or kidney disease. Your doctor should determine if you need a different dose.

    Ask a doctor or pharmacist before use if you aretaking tranquilizers or sedatives.

    When using this product

    • drowsiness may occur
    • avoid alcoholic drinks
    • alcohol, sedatives, and tranquilizers may increase drowsiness
    • be careful when driving a motor vehicle or operating machinery

    Stop use and ask a doctor ifan allergic reaction to this product occurs. Seek medical help right away.

    If pregnant or breast-feeding

    • if breast-feeding: not recommended
    • if pregnant: ask a health professional before use.

    Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

  • Directions

    adults and children 6 years and overone 10 mg tablet once daily; do not take more than one 10 mg tablet in 24 hours. A 5 mg product may be appropriate for less severe symptoms.
    adults 65 years and overask a doctor
    children under 6 years of ageask a doctor
    consumers with liver or kidney diseaseask a doctor
  • Other information

    • TAMPER EVIDENT: DO NOT USE IF IMPRINTED SEAL IS BROKEN OR MISSING FROM BOTTLE.
    • store between 20° to 25° C (68° to 77° F)
  • Inactive ingredients

    corn starch, hypromellose, lactose monohydrate, magnesium stearate, polyethylene glycol, povidone, talc, titanium dioxide

  • SPL UNCLASSIFIED SECTION

    Manufactured for/ Distributed by:

    Marlex Pharmaceuticals, Inc.

    New Castle, DE 19720

    Rev. 10/22 SP

  • PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label

    NDC 10135-0762-30

    Allergy Relief
    Cetirizine HCl Tablets, USP 10 mg
    ANTIHISTAMINE

    30 TABLETS

    label1

  • PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label

    762-90NDC 10135-0762-90

    Allergy Relief
    Cetirizine HCl Tablets, USP 10 mg
    ANTIHISTAMINE

    90 TABLETS

  • PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label

    NDC 10135-0762-01

    Allergy Relief
    Cetirizine HCl Tablets, USP 10 mg
    ANTIHISTAMINE

    100 TABLETS

    762-01

  • PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label

    NDC 10135-0762-03

    Allergy Relief
    Cetirizine HCl Tablets, USP 10 mg
    ANTIHISTAMINE

    300 TABLETS

    label3

  • PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label

    NDC 10135-0762-05

    Allergy Relief
    Cetirizine HCl Tablets, USP 10 mg
    ANTIHISTAMINE

    500 TABLETS

    0762-05

  • INGREDIENTS AND APPEARANCE
    CETIRIZINE HYDROCHLORIDE 
    cetirizine hydrochloride tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10135-762
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CETIRIZINE HYDROCHLORIDE (UNII: 64O047KTOA) (CETIRIZINE - UNII:YO7261ME24) CETIRIZINE HYDROCHLORIDE10 mg
    Inactive Ingredients
    Ingredient NameStrength
    POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)  
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    TALC (UNII: 7SEV7J4R1U)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    Product Characteristics
    ColorwhiteScoreno score
    ShapeRECTANGLE (rounded-off) Size9mm
    FlavorImprint Code RI52
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:10135-762-3030 in 1 BOTTLE; Type 0: Not a Combination Product10/01/2022
    2NDC:10135-762-9090 in 1 BOTTLE; Type 0: Not a Combination Product10/01/2022
    3NDC:10135-762-03300 in 1 BOTTLE; Type 0: Not a Combination Product10/01/2022
    4NDC:10135-762-05500 in 1 BOTTLE; Type 0: Not a Combination Product10/01/2022
    5NDC:10135-762-01100 in 1 BOTTLE; Type 0: Not a Combination Product10/01/2022
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA07749810/01/2022
    Labeler - Marlex Pharmaceuticals, Inc (782540215)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!